Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2023-06-20 00:00:00 ET · period of report 2023-06-15 · accession 0001104659-23-072866 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-20 | 2023-06-15 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | S - Sale+OE | $50.85 | -36.9K | 130.6K | -22% | -$1.87M |
| D | 2023-06-20 | 2023-06-15 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $19.79 | +36.9K | 142.5K | +35% | +$729.6K |
| D | 2023-06-20 | 2023-06-15 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $0.00 | -36.9K | 15.1K | -71% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-15 | S | D | 12,000 | $50.79 | 118,603 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-15 | S | D | 13,000 | $52.79 | 105,603 | D | — | — | |
| 3 | Common | Common Stock | 2023-06-15 | S | D | 11,868 | $48.79 | 130,603 | D | — | — | |
| 4 | Common | Common Stock | 2023-06-15 | M | A | 36,868 | $19.79 | 142,471 | D | — | — | |
| 5 | Derivative | Employee Stock Option (right to buy) | 2023-06-15 | M | D | 36,868 | $0.00 | 15,053 | D | $19.79 · — to 2028-03-15 | 36,868 Common Stock | (F2) Shares subject to the option are fully vested and immediately exercisable. |